Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products, and Combination Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 8, 2024
July 9, 2024
53619b8d-27a9-4506-b006-144d1a9be3d4
Related Documents
Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment
Guidance DocumentSeptember 28, 2023Office of the Commissioner
Setting Endotoxin Limits During Development of Investigational Oncology Drugs and Biological Products Guidance for Industry: Draft Guidance for Industry
Guidance DocumentJuly 28, 2020Center for Drug Evaluation and Research
Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry
Guidance DocumentJuly 6, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.